Towards Healthcare
Antipsychotic Drugs Market Size, Companies and Growth

Antipsychotic Drugs Market Size Envisioned at USD 37.40 Billion by 2032

The report covers Antipsychotic Drugs Market Size and Companies such as Otsuka Holdings Co., Ltd., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Dr. Reddy's Laboratories Limited, AstraZeneca PLC, Johnson & Johnson, Pfizer Inc., Alkermes Plc., AbbVie Inc. and Bristol-Myers Squibb. Segmented by therapeutic class into first and second generation drugs, Applications includes schizophrenia, dementia, bipolar disorder, depression and other applications. Distribution channels include hospital, retail and online pharmacies. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Antipsychotic Drugs Market Assessment

  • Overview
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Antipsychotic Drugs Market Assessment

  • Overview
  • North America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • North America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • North America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Europe Antipsychotic Drugs Market Assessment

  • Overview
  • Europe Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Europe Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Europe Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Asia Pacific Antipsychotic Drugs Market Assessment

  • Overview
  • Asia Pacific Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Asia Pacific Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Asia Pacific Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Middle East and Africa Antipsychotic Drugs Market Assessment

  • Overview
  • Middle East and Africa Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • Middle East and Africa Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • Middle East and Africa Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

South America Antipsychotic Drugs Market Assessment

  • Overview
  • South America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • First Generation
    • Second Generation
  • South America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Schizophrenia
    • Dementia
    • Bipolar Disorder
    • Depression
    • Other Applications
  • South America Antipsychotic Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Company Profiles

  • Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Dr. Reddy's Laboratories Limited
  • AstraZeneca PLC.
  • Johnson & Johnson (Janssen Pharmaceuticals)
  • Pfizer Inc.
  • Alkermes Plc.
  • AbbVie Inc. (Allergan Inc.)
  • Bristol-Myers Squibb

Conclusion & Recommendations

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Rising prevalence of mental illnesses like schizophrenia and bipolar disorder, Growing geriatric population with increased risk of dementia and Increasing government initiatives for mental healthcare awareness and access to medication.

Asia Pacific, due to growing awareness, rising disposable income, and development of local pharmaceutical industries.

Generic alternatives will become available, making treatment more affordable and potentially expanding market reach.

World Health Organization, Food and Drug Administration, Centers for Disease Control and Prevention, HHS.gov. and ScienceDirect.